BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20888240)

  • 1. Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
    Yin W; Majumder S; Clayton T; Petrou S; VanLinn ML; Namjoshi OA; Ma C; Cromer BA; Roth BL; Platt DM; Cook JM
    Bioorg Med Chem; 2010 Nov; 18(21):7548-64. PubMed ID: 20888240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidum.
    June HL; Foster KL; McKay PF; Seyoum R; Woods JE; Harvey SC; Eiler WJ; Grey C; Carroll MR; McCane S; Jones CM; Yin W; Mason D; Cummings R; Garcia M; Ma C; Sarma PV; Cook JM; Skolnick P
    Neuropsychopharmacology; 2003 Dec; 28(12):2124-37. PubMed ID: 12968126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
    Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
    J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
    Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
    J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site.
    Allen MS; Tan YC; Trudell ML; Narayanan K; Schindler LR; Martin MJ; Schultz C; Hagen TJ; Koehler KF; Codding PW
    J Med Chem; 1990 Sep; 33(9):2343-57. PubMed ID: 2167977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
    Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
    Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of aza and carbocyclic β-carbolines for the treatment of alcohol abuse. Regiospecific solution to the problem of 3,6-disubstituted β- and aza-β-carboline specificity.
    Phani Babu Tiruveedhula VV; Methuku KR; Deschamps JR; Cook JM
    Org Biomol Chem; 2015 Nov; 13(43):10705-15. PubMed ID: 26349488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of α1 subtype GABAA receptors attenuates the development of tolerance to the antinociceptive effects of midazolam in rats.
    Lewter LA; Golani LK; Cook JM; Li JX
    Behav Pharmacol; 2021 Jun; 32(4):345-350. PubMed ID: 33290344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore.
    Allen MS; Hagen TJ; Trudell ML; Codding PW; Skolnick P; Cook JM
    J Med Chem; 1988 Sep; 31(9):1854-61. PubMed ID: 2842507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a two-step route to 3-PBC and βCCt, two agents active against alcohol self-administration in rodent and primate models.
    Namjoshi OA; Gryboski A; Fonseca GO; Van Linn ML; Wang ZJ; Deschamps JR; Cook JM
    J Org Chem; 2011 Jun; 76(11):4721-7. PubMed ID: 21495660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Little evidence of a role for the α1GABAA subunit-containing receptor in a rhesus monkey model of alcohol drinking.
    Sawyer EK; Moran C; Sirbu MH; Szafir M; Van Linn M; Namjoshi O; Phani Babu Tiruveedhula VV; Cook JM; Platt DM
    Alcohol Clin Exp Res; 2014 Apr; 38(4):1108-17. PubMed ID: 24330519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the histidine residue at position 105 in the human alpha 5 containing GABA(A) receptor on the affinity and efficacy of benzodiazepine site ligands.
    Kelly MD; Smith A; Banks G; Wingrove P; Whiting PW; Atack J; Seabrook GR; Maubach KA
    Br J Pharmacol; 2002 Jan; 135(1):248-56. PubMed ID: 11786501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a residue in the gamma-aminobutyric acid type A receptor alpha subunit that differentially affects diazepam-sensitive and -insensitive benzodiazepine site binding.
    Derry JM; Dunn SM; Davies M
    J Neurochem; 2004 Mar; 88(6):1431-8. PubMed ID: 15009644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of beta-carboline-benzodiazepine hybrid molecules: use of the known structural requirements for benzodiazepine and beta-carboline binding in designing a novel, high-affinity ligand for the benzodiazepine receptor.
    Dodd RH; Ouannès C; Potier MC; Prado de Carvalho L; Rossier J; Potier P
    J Med Chem; 1987 Jul; 30(7):1248-54. PubMed ID: 3037081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA(A) and opioid receptors of the central nucleus of the amygdala selectively regulate ethanol-maintained behaviors.
    Foster KL; McKay PF; Seyoum R; Milbourne D; Yin W; Sarma PV; Cook JM; June HL
    Neuropsychopharmacology; 2004 Feb; 29(2):269-84. PubMed ID: 14666116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a comprehensive pharmacophore model for the benzodiazepine receptor.
    Zhang W; Koehler KF; Zhang P; Cook JM
    Drug Des Discov; 1995 Jan; 12(3):193-248. PubMed ID: 7662830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
    Im HK; Im WB; Carter DB; McKinley DD
    Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester.
    Hollinshead SP; Trudell ML; Skolnick P; Cook JM
    J Med Chem; 1990 Mar; 33(3):1062-9. PubMed ID: 1968513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.